Difference between revisions of "Cisplatin (Platinol)"
Jump to navigation
Jump to search
m |
|||
| Line 1: | Line 1: | ||
Template to be used for chemotherapies: | Template to be used for chemotherapies: | ||
| + | (strive for minimalism, focus on regimens) | ||
| − | + | ==General information== | |
| − | + | Class: Platinum analog, alkylating-like<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s080lbl.pdf Cisplatin package insert (8/2011)]</ref> | |
| − | + | Extravasation: [[vesicant]] | |
| − | |||
| − | |||
| − | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list additional information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>. | |
| − | |||
| − | |||
| − | + | ==Consent== | |
| − | * | + | *Side effects discussed for informed consent* |
| − | + | *Patient information for informed consent (patient drug information sheet) | |
| − | |||
| − | Side effects | ||
| − | *Patient information for informed consent | ||
| − | |||
| + | ==Regimens== | ||
| + | Standard format will be: | ||
| + | <nowiki><acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease)</nowiki> | ||
[http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin] | [http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin] | ||
==References== | ==References== | ||
| − | + | <references/> | |
Revision as of 07:25, 13 November 2011
Template to be used for chemotherapies: (strive for minimalism, focus on regimens)
General information
Class: Platinum analog, alkylating-like[1] Extravasation: vesicant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list additional information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Consent
- Side effects discussed for informed consent*
- Patient information for informed consent (patient drug information sheet)
Regimens
Standard format will be: <acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease) List of regimens containing cisplatin